Thalidomide as a Steroid Sparing Agent in Refractory Neurosarcoidosis

Update Item Information
Identifier 20010219_nanos_posters_05
Title Thalidomide as a Steroid Sparing Agent in Refractory Neurosarcoidosis
Creator Calkwood, Jonathan C; Maguluri, S
Subject Thalidomide; Refractory Neurosarcoidosis; Steroid Sparing Agent; Macrophages
Description Sarcoid is a multi-system granulomatous disease of unknown etiology that is mediated by macrophages, activated T-cells and cytokines IL-2, IL-12, and TNF alpha. Neurosarcoid occurs in approximately 5% of patients. Corticosteroids are the primary treatment for neurosarcoidosis; however, one-third of patients are refractory to corticosteroids alone and may require a steroid-sparing agent. Thalidomide inhibits macrophages, T-cells and suppresses IL-2 and IL-12 and TNF-alpha.
Date 2001-02-19
Language eng
Format application/pdf
Format Creation application/pdf
Type Text
Source 2001 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2001: Poster Presentations
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2010. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s62z4c4n
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Setname ehsl_novel_nam
ID 182242
Reference URL https://collections.lib.utah.edu/ark:/87278/s62z4c4n
Back to Search Results